Fall-related activity avoidance in relation to a history of falls or near falls, fear of falling and disease severity in people with Parkinson’s disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2377
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Fall-related activity avoidance in relation to a history of falls or near falls, fear of falling and disease severity in people with Parkinson’s disease ; volume:16 ; number:1 ; day:2 ; month:6 ; year:2016 ; pages:1-8 ; date:12.2016
BMC neurology ; 16, Heft 1 (2.6.2016), 1-8, 12.2016
- Creator
-
Kader, Manzur
- Contributor
- DOI
-
10.1186/s12883-016-0612-5
- URN
-
urn:nbn:de:1111-2016060325597
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kader, Manzur
- Iwarsson, Susanne
- Odin, Per
- Nilsson, Maria H.
- SpringerLink (Online service)
Other Objects (12)
Development of a Parkinson’s disease specific falls questionnaire
Falls risk is predictive of dysphagia in Parkinson’s disease
Assessment of fall-related self-efficacy and activity avoidance in people with Parkinson's disease
Prognostic factors for falls in Parkinson’s disease: a systematic review
Longitudinal prediction of falls and near falls frequencies in Parkinson’s disease: a prospective cohort study
Development and Validation of a Fall Questionnaire for Patients with Parkinson’s Disease
Factors associated with fear of falling in people with Parkinson’s disease
Cholinesterase inhibitor to prevent falls in Parkinson’s disease (CHIEF-PD) trial: a phase 3 randomised, double-blind placebo-controlled trial of rivastigmine to prevent falls in Parkinson’s disease
Brain metabolic alterations herald falls in patients with Parkinson's disease
External validation of a 3-step falls prediction model in mild Parkinson’s disease
Axial impairment and falls in Parkinson’s disease: 15 years of subthalamic deep brain stimulation
Experiences of fear of falling in persons with Parkinson’s disease – a qualitative study
Development of a Parkinson’s disease specific falls questionnaire
Falls risk is predictive of dysphagia in Parkinson’s disease
Assessment of fall-related self-efficacy and activity avoidance in people with Parkinson's disease
Prognostic factors for falls in Parkinson’s disease: a systematic review
Longitudinal prediction of falls and near falls frequencies in Parkinson’s disease: a prospective cohort study
Development and Validation of a Fall Questionnaire for Patients with Parkinson’s Disease
Factors associated with fear of falling in people with Parkinson’s disease
Cholinesterase inhibitor to prevent falls in Parkinson’s disease (CHIEF-PD) trial: a phase 3 randomised, double-blind placebo-controlled trial of rivastigmine to prevent falls in Parkinson’s disease
Brain metabolic alterations herald falls in patients with Parkinson's disease
External validation of a 3-step falls prediction model in mild Parkinson’s disease
Axial impairment and falls in Parkinson’s disease: 15 years of subthalamic deep brain stimulation
Experiences of fear of falling in persons with Parkinson’s disease – a qualitative study
Development of a Parkinson’s disease specific falls questionnaire
Falls risk is predictive of dysphagia in Parkinson’s disease
Assessment of fall-related self-efficacy and activity avoidance in people with Parkinson's disease
Prognostic factors for falls in Parkinson’s disease: a systematic review
Longitudinal prediction of falls and near falls frequencies in Parkinson’s disease: a prospective cohort study
Development and Validation of a Fall Questionnaire for Patients with Parkinson’s Disease
Factors associated with fear of falling in people with Parkinson’s disease
Cholinesterase inhibitor to prevent falls in Parkinson’s disease (CHIEF-PD) trial: a phase 3 randomised, double-blind placebo-controlled trial of rivastigmine to prevent falls in Parkinson’s disease
Brain metabolic alterations herald falls in patients with Parkinson's disease
External validation of a 3-step falls prediction model in mild Parkinson’s disease
Axial impairment and falls in Parkinson’s disease: 15 years of subthalamic deep brain stimulation